Therapeutic Indications

Cefditoren is indicated for:

at least one of
at least one of
Staphylococcus aureus

Streptococcus, group C

Streptococcus, group G

Streptococcus agalactiae

Streptococcus pneumoniae

Streptococcus pyogenes

Haemophilus influenzae

Moraxella (Branhamella) catarrhalis

Clostridium perfringens

and additionally at least one of
Respiratory tract infection

Infection of skin

Acute pharyngitis

Acute tonsillitis

Acute maxillary sinusitis

Acute bronchitis due to Haemophilus influenzae

Acute bronchitis due to streptococcus

Acute bronchitis due to other specified organisms

Pneumonia due to Streptococcus pneumoniae

Pneumonia due to Haemophilus influenzae

Pneumonia due to staphylococcus

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral


Active ingredient Cefditoren is contraindicated in the following cases:

No gender/age discrimination

at least one of


H2-receptor antagonists